Selling Your Veterinary Practice to VetnCare: A 2026 Guide

Key takeaways

• VetnCare is a regional veterinary group — approximately 13 AAHA-accredited hospitals across Northern California and the San Francisco Bay Area, founded in 2012 and headquartered in Oakland.
• Great Point Partners, a Greenwich, Connecticut healthcare-focused private equity firm, partnered with VetnCare at the end of 2022; the group has more than doubled in size since.
• The model is legacy-first and local. Per VetnCare’s own materials, most hospitals “continue operating much as they always have,” keeping their name, team, and community standing, while a centralized Community Leadership Team handles the back office.
• Leadership today: CEO Matthew J. Kirchner (appointed January 2025), with founder Dr. Andrew Moffatt continuing as Chief Medical Officer.
• The reliable way to learn what VetnCare — or any buyer — would actually pay for your specific practice is to run a structured competitive process. We call ours the Elite Selling System: we hand-select and vet every buyer who gets to bid, the way a doorman with a velvet rope lets in only the right people, then run a private bidding window inside that vetted group.

When a Bay Area vet asks me about selling your veterinary practice to VetnCare, the conversation usually starts somewhere local. Not “who is this national platform.” More like “I know two practices down the road that joined them.” VetnCare is a regional group, not a coast-to-coast roll-up, and that single fact changes the whole shape of the decision in front of an owner in San Francisco, Oakland, the East Bay, or the Peninsula.

That regional footprint is the through-line of every VetnCare conversation. The group is concentrated in one geography, it markets itself on keeping local hospital identity, and it sits behind a healthcare-focused private equity backer.

Those three things — local density, legacy preservation, and a financial sponsor — are the lenses worth holding any VetnCare offer up against.

Here’s the picture I’d lay out over dinner if a vet handed me a VetnCare term sheet and asked what to make of it. Who owns VetnCare, what the regional model actually means for a seller, what the company says it offers, and the specific terms you need to pin down in writing before you sign anything.

Who owns VetnCare? (Great Point Partners and the 2022 partnership)

VetnCare is a portfolio company of Great Point Partners (GPP), a Greenwich, Connecticut private investment firm focused exclusively on healthcare. Great Point partnered with VetnCare at the end of 2022 to support its expansion, and lists VetnCare on its active private-equity portfolio page as a “Veterinary Services Provider Based in Northern California.” Day-to-day leadership sits with CEO Matthew J. Kirchner; founder Dr.

Andrew Moffatt continues as Chief Medical Officer.

This makes VetnCare a PE-backed group. A private equity firm provides the capital and the growth mandate, while the operating team runs the hospitals.

Great Point Partners is not a generalist fund dabbling in pets. Per its own portfolio materials, the firm has invested in 35-plus private healthcare businesses since 2003, spanning healthcare services, biopharma supply chain, healthcare IT, and medical-device contract manufacturing.

What that ownership picture means for a seller is straightforward. You’re partnering with a regional operating group that has institutional healthcare capital behind it, a defined growth plan, and the eventual liquidity horizon that comes with any private equity sponsor.

None of that is a knock. It’s simply the structure, and it’s worth understanding before you read the deal terms.

VetnCare’s footprint: approximately 13 Northern California / Bay Area hospitals

VetnCare is approximately 13 veterinary hospitals across Northern California and the San Francisco Bay Area, per the company’s own About materials. It describes itself as a “clinically-led collaboration of AAHA accredited hospitals within the San Francisco Bay Area,” founded in 2012 with the stated vision of delivering “next-level care, next-door.”

The group has grown fast under its sponsor. Per Great Point Partners, VetnCare has more than doubled in size since 2022, when the partnership began — so the live hospital count keeps moving.

Treat 13 as a recent figure, not a fixed one.

The footprint matters more here than it does with the national consolidators. VetnCare is, by every primary source, a regional operator, with no public evidence of acquisition activity outside Northern California.

That regional density is the model’s whole logic.

For an owner whose practice sits inside that geography, the regional concentration cuts in your favor. Referral relationships, shared specialty coverage, recruiting reach, and back-office support are all easier to deliver when your hospital tucks into an existing cluster of nearby VetnCare locations.

For an owner outside Northern California, VetnCare simply isn’t the buyer, and that’s useful to know early, because it tells you which field of buyers actually competes for your practice. Our guide to veterinary practice consolidators maps the broader field of national and regional buyers.

The VetnCare model: a regional, clinically-led group keeping local identity

VetnCare’s services span general practice and wellness plus advanced surgery, advanced imaging, urgent care, dermatology, exotics, and other specialties across the network, per its company materials. The hospitals are described as AAHA-accredited — the American Animal Hospital Association’s voluntary accreditation, which is a recognized quality standard in companion-animal medicine.

The defining feature of the model is its local-identity posture. VetnCare partners with owners “who want to preserve their legacy,” and per its seller materials, most hospitals “continue operating much as they always have” — keeping their name, their team, and their standing in the community.

That’s a meaningful distinction in the buyer landscape. Most PE-backed groups generally preserve local practice branding rather than rebranding, and VetnCare leans into that explicitly.

The familiar exception is Mars Veterinary Health (VCA, Banfield, BluePearl), the family-owned strategic buyer that has historically been more willing to transition acquired practices toward a network brand over time.

The other half of the model is centralized support. VetnCare’s Community Leadership Team provides back-office services across operations, finance, IT, HR, and marketing, so hospital teams can focus on patient care.

For a long-time owner tired of wearing the operator hat (payroll, vendor contracts, HR headaches, the marketing nobody has time for), that centralization is often the part of the pitch that lands hardest.

What VetnCare says it offers sellers: legacy, autonomy, and back-office support

VetnCare’s seller pitch comes down to three promises, all drawn from its own Partner With Us materials. It’s worth reading them as stated promises — useful, but to be confirmed in your contract, not assumed.

Legacy preservation. VetnCare says it “partners with owners who want to preserve their legacy,” with most hospitals continuing to operate much as they always have. The name stays, the team stays, the community standing stays.

Clinical autonomy. VetnCare states that after partnership, clinical decisions remain with the practice’s veterinarians, “while following shared standards of practice across our community.” In plain terms: you keep medical control, inside a set of network-wide standards.

Operational relief. The Community Leadership Team absorbs the back office — operations, finance, IT, HR, marketing — so the clinical team isn’t also running the administrative machine.

One leadership note worth weighing. CEO Matthew Kirchner, appointed in January 2025, spent the majority of his career in human healthcare (health care services, medical devices, biotech, and pharma) before veterinary.

That’s an increasingly common profile among PE-backed veterinary leaders, and it tends to signal a disciplined, systems-oriented operating approach. Founder Dr.

Andrew Moffatt staying on as Chief Medical Officer keeps a veterinary clinician at the top of the medical side.

How VetnCare compares to national consolidators for a Bay Area seller

If you’re weighing VetnCare, you’re really weighing “regional group” against “national platform.” Here’s how the trade-offs break down on the dimensions sellers care about. Every cell below describes a structural difference, not a value judgment — both models place good practices well.

Dimension	VetnCare (regional group)	National PE-backed platforms
Geographic focus	Northern California / SF Bay Area	Multi-region or nationwide
Ownership	Great Point Partners (healthcare PE), since 2022	Various PE sponsors or strategic owners
Local brand	Preserved per company materials	Many preserve local brand; one strategic buyer (Mars) historically rebrands
Scale of network	~13 hospitals, regionally dense	Hundreds to thousands of hospitals
Local referral / specialty density	High within the Bay Area	Varies by market
Best fit for	Established Bay Area practices wanting to stay local	Practices anywhere, or those wanting national-platform scale

The honest read: for an established Bay Area practice that wants to stay regional and keep its identity, a dense local group like VetnCare can be a genuinely strong cultural and operational fit. For an owner who wants to test the absolute top of the market, the right move is to make sure VetnCare’s number is measured against the national buyers too — which only happens in a competitive process.

Our PE pricing guide covers how those buyer types tend to structure offers.

Leadership today: founder Dr. Andrew Moffatt and CEO Matthew Kirchner

The leadership structure tells you something about how a VetnCare partnership is likely to feel post-close. You have a career human-healthcare operator running the business and the original veterinary founder running the medicine.

Kirchner’s January 2025 appointment is recent, which is worth noting simply because the leadership chapter you’d be joining is a new one. The operating playbook under his tenure is still being established.

Moffatt’s continuity as Chief Medical Officer is the counterweight: the clinical philosophy that built VetnCare from 2012 still has its founder at the top of the medical org.

For a seller, the practical question is what the regional operating structure means for your day-to-day after closing. Where do clinical decisions sit?

Which business decisions migrate to the Community Leadership Team? That’s exactly the kind of thing to get specified, not assumed — which brings us to the terms.

What to verify before signing: deal structure, equity, and post-sale terms

Here’s the part I’d circle hardest. VetnCare’s public seller materials don’t disclose deal structure. There’s no published detail on whether it offers rollover equity, a partnership/JV stake, earnouts, or how it splits cash at close versus deferred consideration. That’s normal; almost no buyer publishes terms.

It just means you confirm each one directly rather than inferring it.

Six things to pin down in writing before you sign:

Cash at close versus earnout. An earnout is part of the price paid later, payable only if the practice hits agreed targets after closing. Ask what share of total value is guaranteed cash at close versus contingent, and exactly how any earnout target is measured.

Indemnification holdback. Many deals include a holdback — a slice of the price the buyer retains and pays out later, over a defined period, to back your representations. In these deals the buyer wires the agreed amount directly to you at close and simply holds back the indemnity portion; there’s no third party sitting in the middle of the money.

Confirm the amount, the hold period, and the release conditions.

Rollover equity or partnership stake. Ask whether rollover equity, meaning you keep a slice of ownership in the new entity instead of taking all cash, is on the table. If so, nail down the liquidity timing, the formula, and your governance and information rights.

Post-sale employment. What’s the required term, the compensation structure (base plus production is the common shape across the industry), and what happens to your comp if production shifts post-close.

Non-compete scope. Confirm the duration and the geographic radius, and whether there’s any carve-out for specialty work or future clinical activity.

Clinical autonomy and brand preservation in writing. VetnCare’s materials promise both. Marketing language and a contractual commitment aren’t the same thing — get the autonomy boundaries and the brand-preservation promise into the definitive agreement.

If you want a plain-English walk-through of how these pieces fit together, our guide on how to valuate a veterinary practice and the broader who to sell your veterinary practice to overview both go deeper.

Have an offer from VetnCare? Get a Free Practice Value Estimate — send us the offer and we’ll decompose the terms, flag what’s typically negotiable, and project what your practice would likely clear in a structured competitive process across the qualified buyer pool. No upfront cost, no obligation.

Is VetnCare the right buyer for your practice? Key questions to ask

For a Northern California or Bay Area owner, VetnCare belongs on the list of buyers worth taking seriously. A regionally dense, AAHA-accredited group that keeps your name and absorbs your back office is a real fit for an owner who wants to stay local and step back from operations without uprooting the practice they built.

But “a good fit” and “the best outcome” aren’t the same question. The consistent pattern we see is that any single buyer’s first offer, VetnCare’s included, reflects the leverage that buyer perceives in the room. A buyer facing no visible competition has no structural reason to lead with its strongest cash percentage, tightest earnout terms, or most flexible autonomy language.

When other qualified buyers are underwriting the same practice in parallel, those dimensions tend to move. That’s not unique to VetnCare; it’s how every buyer calibrates an offer to the situation in front of it.

This is where the Elite Selling System earns its keep. We hand-select and vet every buyer who gets to bid on your practice, the way a doorman with a velvet rope lets in only the right people, then run a private competitive window inside that vetted group.

For a Bay Area practice, that group naturally includes VetnCare alongside the national platforms that also compete in California, so you see how a regional group and a national buyer each value the exact same practice, side by side.

When we prepare a practice for sale, part of the work is a thorough pre-sale financial review on our side of the table, built around the same scrutiny a buyer’s accountants will run, but done months before any buyer sees your numbers. That gives us time to clean up anything that wouldn’t survive a deep look, so your EBITDA, what your practice earns in pure operating profit before taxes and accounting choices, holds up when it counts.

The practices in our deal flow that run a competitive process consistently clear materially better total outcomes than they would have by signing the first direct term sheet. Whether that first term sheet comes from VetnCare or anyone else, the highest-leverage move is the same: understand the whole field before you commit.

If you’d like that comparison for your practice, Get a Free Practice Value Estimate and we’ll lay it out the way I would across a dinner table. Our sell my veterinary practice guide covers the full process end to end.

Frequently asked questions

Who owns VetnCare? VetnCare is a portfolio company of Great Point Partners, a Greenwich, Connecticut private investment firm focused exclusively on healthcare. Great Point partnered with VetnCare at the end of 2022 to support its expansion.

Day-to-day, VetnCare is led by CEO Matthew J. Kirchner, appointed in January 2025; founder Dr.

Andrew Moffatt continues as Chief Medical Officer.

Is VetnCare private equity-backed? Yes. VetnCare is a current portfolio company of Great Point Partners, a healthcare-focused private equity firm, listed on Great Point’s active portfolio page as a veterinary services provider based in Northern California.

The partnership began at the end of 2022. Great Point Partners has invested in 35-plus private healthcare businesses since 2003.

How many hospitals does VetnCare have? VetnCare is approximately 13 veterinary hospitals across Northern California and the San Francisco Bay Area, per the company’s own materials. The group has more than doubled in size since 2022, when it began its partnership with Great Point Partners, so the live count grows over time.

Where is VetnCare located? VetnCare is a regional operator concentrated in Northern California and the San Francisco Bay Area, headquartered in Oakland, California. Every primary source describes it as a Bay Area / Northern California group; there is no public evidence of acquisition activity outside that footprint.

Does VetnCare let veterinarians keep clinical autonomy after selling? Per VetnCare’s seller materials, clinical decisions remain with the practice’s veterinarians after partnership, while following shared standards of practice across the community. VetnCare also states that most hospitals continue operating much as they always have, keeping their identity, team, and community standing.

The specific autonomy and governance terms for any deal are set in the definitive purchase agreement and should be confirmed in writing.

Who is the CEO of VetnCare? Matthew J. Kirchner was appointed CEO of VetnCare on January 28, 2025.

He spent the majority of his career in human healthcare — health care services, medical devices, biotech, and pharma — before joining the veterinary field. Founder Dr.

Andrew Moffatt transitioned to Chief Medical Officer.

Is VetnCare a good company to sell my practice to? VetnCare can be a strong fit for an established Bay Area or Northern California practice that wants to stay regional, keep its name, and join an AAHA-accredited group with centralized back-office support. As with any buyer, the way to know what VetnCare would actually offer is to run a structured competitive process so its bid is tested against other qualified buyers underwriting the same practice.

What should I verify before selling my practice to VetnCare? Get the deal structure in writing: cash at close versus earnout and any indemnification holdback, whether rollover equity or a partnership stake is offered, the post-sale employment term and compensation formula, the non-compete scope, and the clinical-autonomy and brand-preservation language. VetnCare’s seller materials do not publicly disclose these terms, so confirm each one directly before signing.

Sources

Buyer and parent-company materials

1. Great Point Partners. “Portfolio & Case Studies.” gppfunds.com
2. Great Point Partners. “VetnCare Announces Matthew J. Kirchner as Chief Executive Officer; Founder Dr. Andrew Moffatt to Continue Leadership Role as Chief Medical Officer.” January 28, 2025. gppfunds.com
3. BusinessWire / Great Point Partners. “VetnCare Announces Matthew J. Kirchner as Chief Executive Officer.” January 28, 2025. businesswire.com
4. VetnCare. “About VetnCare.” vetncare.com
5. VetnCare. “Partner With Us.” vetncare.com

Company profile and operations data

6. LeadIQ. “VetnCare company profile.” leadiq.com
7. PitchBook. “VetnCare company profile.” pitchbook.com

Veterinary profession and accreditation references

8. American Animal Hospital Association (AAHA). “AAHA accreditation standards.” aaha.org
9. American Veterinary Medical Association (AVMA). “AVMA data and insights.” avma.org